News: Latest Posts
Wellcome Trust Grant
MicroPharm Limited is pleased to announce that it has been awarded a grant by the Wellcome Trust to progress a project entitled “A Rapid and Substantial Increase in Supplies of an Effective, Safe and Affordable Antivenom to sub-Saharan Africa”.
Read the full storyPosted on: Wednesday, 30th June 2021
Acquisition of Sanofi Pasteur’s Equine Antivenom Immunoglobulin Products
MicroPharm Limited is pleased to announce the acquisition of Sanofi Pasteur’s antivenom equine immunoglobulin product range comprising Viperfav®, Bothrofav® Scorpifav®, Fav-Afrique® and Favirept®.
Read the full storyPosted on: Tuesday, 2nd January 2018
MicroPharm Secures Biomedical Catalyst 2016 Grant
MicroPharm Limited announced that it has secured a grant of £195,567 to further support the development of OraCAb, a therapeutic for oral administration of polyclonal antibodies to treat Clostridium difficile infections.
Read the full storyPosted on: Wednesday, 1st February 2017
MicroPharm Secures SMART Grant
MicroPharm Limited announced that it has secured a grant of £195,373 to further support the development of OraCAb, a therapeutic for oral administration of polyclonal antibodies to treat Clostridium difficile infections. This is funding from the European Regional Development Fund (ERDF) under the Welsh government operational programme SMART Cymru West Wales and the Valleys 2014-2020.
Read the full storyPosted on: Thursday, 1st December 2016
Contract Awarded for Manufacture of a Ricin Antitoxin
MicroPharm Limited is pleased to announce the award of a contract offered by the Defence Science and Technology Laboratory (Dstl) on behalf of the Ministry of Defence (MOD) to manufacture a ricin antitoxin.
Read the full storyPosted on: Tuesday, 23rd August 2016